U
Upstream Bio, Inc.
UPB · NASDAQ · Healthcare · 385M
Closing price
$4.70
+3.30% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
-1.1×
Free cash flow yieldFCF yield
-52.7%
Return on equityROE
-42.2%
Operating margin
-5618.8%
Net debt / EBITDAbalance-sheet strength
0.7×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.